GeneHarbor focuses on the development of innovative biotech products, enzymes in particular, and medical products.

Enzymes are responsible for most biochemical processes in living organisms. In recent years, the application of enzymes in industrial, agricultural, pharmaceutical and environmental sectors have expanded rapidly. The enzyme industry, with an annual output in excess of US$2 billion in 2002, has become one of the main streams in biotechnology.

GeneHarbor has developed an enzyme optimization technology platform, which integrates the current knowledge and techniques in genetic engineering, protein engineering, biochemistry, genetics, industrial fermentation, bio-informatics, organic chemistry, computer design, high-throughput-screening and industrial enzymology. The technology is highly effective in generating novel products tailored for industrial, agricultural, pharmaceutical and environmental application.

The company has entered a rapid growing phase for the next few years and beyond, with its profit of 2007 increased over six folds over the previous year.